Origin Pharma Packaging will be exhibiting at the CPhI Barcelona, where it will launch its latest packaging innovations.

Origin has designed two revolutionary PP28 child resistant closures, developed to offer flexibility within the marketplace. Designed, engineered, and strategically optimised to be the lightest PP28 closure of its type, this exciting closure development encapsulates the drive to have a dynamic closure, which not only delivers a solution to the call for reduced polymer weight but also provides a truly flexible approach to design and delivery.

In addition to reduced polymer content, this closure can be branded, bulk packed, and produced in a range of colours at lower volumes than normally required. A range of clip-in liners and attachments are also available for this new device and over-printing of the embossing is optional.

Approved to ISO8317 and 16CFR1700.20, this product presents a solution to child safe compliance wherever you are in the world. The closure is designed to assist you in your drive for brand dominance by utilising the flexible features of this primary packaging component. You are able to deliver branding using the colour applicable to your brand and also to have your brand logo embossed on the crown of the cap. Differentiating the primary packaging from competitors in today’s market is paramount. With the new PP28 closure, this possibility becomes reality.

The new PP28 closure development will offer the service of bulk packing with the ability to reduce outer packaging by up to 25%. Its development has also been thoughtfully compiled to ease the legislative and regulative burdens on companies to increase sustainability within their supply chain. The project will reduce materials used to enable users to reduce their carbon footprint and reduce costs in transportation. The light-weighting of the closure has evolved over many months and great care taken to ensure the efficacy of the child resistance is not compromised.

Many OTC products produced are now being advised to have a dosage device included in the packaging. The optional, pre-fitted SealSafe adaptor is a new generation device, which uses valve technology to prevent unintended access to your product whilst providing easy and accurate dispensing with minimal risk to over-dosing. The SealSafe device also provides a measure of protection against falsified medicines.

The PP28 closure can be manufactured in cleanroom environment using food-grade or EP approved polymer which provides a guarantee of integrity in terms of pharmaceutical standards. The closure is produced at a fully accredited ISO13485 (medical devices) site under controlled manufacturing conditions.

Jon Lant, New Product Development Director explains the new PP28 (development one of two), "We are excited about the opportunities for this product and the ability to deliver flexibility in what is often a very prescribed market. The development has been led by demand and in consideration of a call for flexibility, diversification and brand promotion. Coupled with a flexible end-to-end supply chain solution we are answering the needs of pharmaceutical companies who require improved availability and reduced waste".

In conjunction with the PP28 closure, a bespoke measuring beaker has been developed. A perfect fit in combination, this provides an alternative low-cost option to accurate dosing with custom embossing available to assist the correct dosing of your product.

Origin Pharma Packaging will be exhibiting at CPhI Barcelona from the 4 October to the 6 October.